Monitor for potential downward pressure on CYTK shares as the offering closes May 8, given the dilutive nature. The stock may trade around the $71 offering price near-term. Watch for any post-offering price support from underwriters.
CYTK drugs
CYTK drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 7 $74.29entry
- T+1 · 6mo ago +3.53%α +2.70% · $76.91
- T+5 · 6mo ago +3.94%α +2.44% · $77.22
- T+20 · 6mo ago −4.82%α −7.95% · $70.71
- T+60 · 4mo ago +2.91%α −0.93% · $76.45
Price Chart
How similar events traded
Executive Summary
Cytokinetics priced a $700 million public offering of 9.86 million shares at $71.00 per share, with an underwriter option for an additional 1.48 million shares. The offering represents approximately 7.3% dilution to existing shareholders and will close on May 8, 2026.
Key Financial Metrics
Key Facts
- 9,859,155 shares offered at $71.00/share for ~$700M gross proceeds
- Underwriters have 30-day option to purchase up to 1,478,873 additional shares
- Offering represents ~7.3% dilution (8.4% if greenshoe exercised)
- Morgan Stanley, Goldman Sachs, J.P. Morgan, and Jefferies are joint book-runners
- Closing expected May 8, 2026
Financial Impact
~$700M gross proceeds, ~7-8% dilution to existing shareholders
Risk Factors
- Equity dilution of ~7-8%
- Potential overhang from additional shares if greenshoe exercised
- Use of proceeds not specified, adding uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3289552 |
Track record
46 reports on CYTK
6 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $56.13 +4.41% settles Dec 15
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $56.13 +0.00% settles Dec 14
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $56.13 −0.09% settles Dec 9
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $56.13 −0.09% settles Dec 9
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $56.13 +1.80% settles Dec 8
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $56.13 +1.80% settles Dec 8
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $56.13 +1.04% settles Dec 4
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $56.13 −11.75% settles Dec 3
- Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $56.13 −9.51% settles Dec 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers